Regulatory preclinical studies for COVID-19 drug development

SOURIS JSP 300X225

Service description

  • All regulatory tests necessary for COVID-19 preclinical drug development dossier: toxicity, carcinogenicity, in vitro and in vivo in small animals.
  • This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the request.
  • A specific regulatory process may be required for project approval.

  • Further details on the project may be requested.
  • You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert.
Formulaire

Get started with your COVID-19 preclinical in vivo and in vitro tests

Please answer the fields below to be contacted by our team of scientists
favicon large un peu plus-1